Searchable abstracts of presentations at key conferences in endocrinology

ea0021p82 | Clinical practice/governance and case reports | SFEBES2009

Audit of hypothyroid management in pregnancy

Rajeev Surya , Jones Rebecca , White Helen

Introduction: Hypothyroidism in pregnancy may be associated with neurodevelopmental delay of the unborn baby. Timely management of abnormal thyroid function tests (TFTs) in pregnancy is important. In our centre, some patients attend an Endocrinology-led dedicated antenatal thyroid clinic, whilst others attend an Obstetrician-led general antenatal clinic.Objectives: The management of hypothyroid pregnant patients attending our centre was audited against T...

ea0015p229 | Pituitary | SFEBES2008

Multiple endocrine neoplasia type 1 presenting with pituitary apoplexy

White Helen , Javadpour Mohsin , MacFarlane Ian

Pituitary apoplexy (characterised by sudden onset headache, meningism and cranial nerve defects) is an unusual but serious complication of pituitary macroadenoma. Less than 2 percent of patients with pituitary macroadenoma present initially with apoplexy. Pituitary adenoma is the presenting feature in 10–25% of cases with multiple endocrine neoplasia (MEN) type 1, with microadenomas accounting for 2/3 of MEN-related pituitary adenomas.A 35-year-old ...

ea0013p313 | Thyroid | SFEBES2007

Effects of neurotensin and/or morphine on gene expression of mu and delta opioid receptor

White Helen , Hayden Katharine , MacFarlane Ian

Factitious thyrotoxicosis secondary to Levo-thyroxine accounts for approximately 0.3% of all cases of hyperthyroidism. Although recognised as a cause of thyrotoxicosis, there are no peer-reviewed published cases of thyrotoxicosis secondary to ingestion of Tri-iodothyronine.A 23-year old lady presented to endocrine clinic with a 6-month history of palpitations, heat intolerance and tremor. She had a history of PCOS and reported difficulties with weight co...

ea0015p173 | Endocrine tumours and neoplasia | SFEBES2008

The management of multiple endocrine neoplasia type 1: 5-year experience of a multidisciplinary clinic

White Helen , Blair Jo , Weber Astrid , Pinkney Jonathan , MacFarlane Ian

The multiple endocrine neoplasia (MEN) clinic at our hospital was established in 2002 with the aim of providing integrated, comprehensive and expert regional care to patients with MEN syndrome. The clinical team consists of an adult endocrinologist, a paediatric endocrinologist, a clinical geneticist and an endocrine surgeon.In 2002, 16 patients with MEN type 1 from five different kindred were seen. These patients had previously been attending a combinat...

ea0013p11 | Bone | SFEBES2007

Alendronate accelerates increases in bone mineral density with growth hormone replacement but may attenuate the anabolic effect of growth gormone replacement on bone in adult growth hormone deficiency

White Helen , Ahmad Aftab , Durham Brian , Fraser William , Vora Jiten

Introduction: Adult Growth Hormone Deficiency (AGHD) is associated with osteoporosis. Underlying mechanisms involved in the pathogenesis include reduced target-organ sensitivity to the effect of PTH. Growth Hormone Replacement (GHR) in AGHD leads to increased PTH target-organ sensitivity and consequently increased bone turnover and bone mineral density (BMD).Aims: We determined the effect of alendronate, given in addition to GHR, on PTH target-organ sens...

ea0019p11 | Bone | SFEBES2009

Impact of body mass index at baseline on parathyroid hormone and phospho-calcium metabolism in adult growth hormone deficient patients before and after growth hormone replacement therapy

Mon Aung , Ahmad Aftab , Malipatil Nagaraj , Joseph Franklin , White Helen , Joshi Ashwin , Sharma Dushyant , Fraser William , Vora Jiten

Background: Adult growth hormone deficient (AGHD) is associated with reduced bone turnover and reduced bone mineral density (BMD): factors improved by growth hormone replacement (GHR). Obesity is associated with reduced bone turnover but increased BMD. We investigated the impact of body mass index on parathyroid hormone (PTH), phospho-calcium metabolism and bone turnover in AGHD patients before and after GHR.Study design: Of 31 AGHD patients (15 obese pa...